C. Barone

Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study

Carmelo Pozzo, C. Barone, J. Szántó et al. · Annals of Oncology · 2004 · 157 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial

Lucia Del Mastro, Mauro Mansutti, Giancarlo Bisagni et al. · The Lancet Oncology · 2021 · 86 citations

Medicine, Oncology, Breast Oncology +14

Concomitant Adjuvant Chemoradiotherapy with Weekly Low-dose Cisplatin for High-risk Squamous Cell Carcinoma of the Head and Neck: a Phase II Prospective Trial

Monica Rampino, Umberto Ricardi, F. Longo Muñoz et al. · Clinical Oncology · 2010 · 44 citations · Full text

Medicine, Oncology, Radiation Oncology +12

Gefitinib (ZD1839): Therapy in selected patients with non-small cell lung cancer (NSCLC)?

Diego Dongiovanni, Lorenzo Daniele, C. Barone et al. · Lung Cancer · 2008 · 23 citations

Medicine, Pharmacology, Pharmacotherapy +7

High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors: mature results of an Italian randomized phase II study

Andrea Necchi, Luigi Mariani, Massimo Di Nicola et al. · Annals of Oncology · 2014 · 21 citations · Full text

Medicine, Oncology, Chemotherapy +8